Prostate Neoplasm Clinical Trial
Official title:
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion
This study evaluates contrast-enhanced MR angiography and contrast-enhanced MR perfusion imaging for the visualization of blood vessels and enhancing tissues with better spatial detail and improved temporal fidelity compared to current methods.
PRIMARY OBJECTIVE: I. To study how a variety of technological approaches in MRI can be used to provide improved performance contrast-enhanced MR imaging as used for angiography and perfusion. OUTLINE: This is an observational study. Participants are assigned to 1 of 3 groups. GROUP 1: Participants undergo magnetic resonance imaging (MRI) on study. Participants may also undergo blood sample collection on study. GROUP 2: Participants receive gadolinium based MR contrast agent intravenously (IV) and undergo MRI on study. Participants may also undergo blood sample collection on study. GROUP 3: Participants receive gadolinium based MR contrast agent IV and undergo up to two MRIs on study. Participants may also undergo blood sample collection on study. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT05191017 -
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC
|
Phase 1/Phase 2 | |
| Completed |
NCT00255125 -
Role of Soy Supplementation in Prostate Cancer Development
|
Phase 3 | |
| Terminated |
NCT02809690 -
18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer
|
Phase 1 | |
| Completed |
NCT06020287 -
The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior Approach
|
||
| Recruiting |
NCT03572946 -
Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection
|
N/A | |
| Active, not recruiting |
NCT03344757 -
Health Gatherings - For Your Health After Cancer
|
N/A | |
| Recruiting |
NCT05137561 -
Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed TRUS Guided Prostate Biopsy
|
N/A | |
| Recruiting |
NCT04792138 -
Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis.
|
||
| Completed |
NCT03702439 -
Prostate Cancer Screening Trial Using Imaging
|
||
| Completed |
NCT04852224 -
Strength, Aging, and Memory in Prostate Cancer
|
||
| Completed |
NCT01240551 -
F-18 Sodium Fluoride in Prostate Cancer
|
Phase 2 | |
| Not yet recruiting |
NCT06430411 -
Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study
|
||
| Recruiting |
NCT02436122 -
Impact of Preoperative HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate Cancer
|
N/A | |
| Active, not recruiting |
NCT03493945 -
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
|
Phase 1/Phase 2 | |
| Completed |
NCT04376008 -
A Prospective Study Of Free-Hand Transperineal Image Fusion Targeted Biopsies Under Local Anesthesia
|
N/A | |
| Recruiting |
NCT05252390 -
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06292897 -
Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression
|
||
| Recruiting |
NCT03819751 -
MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer Detection
|
N/A | |
| Not yet recruiting |
NCT05460312 -
Protein Kinase A in Prostate Cancer Tissue.
|
||
| Completed |
NCT00005916 -
PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer
|
Phase 2 |